ArticleBlood2025

Evaluating the impact of CRBN mutations on response to immunomodulatory drugs and novel cereblon E3 ligase modulators in myeloma.

Yakinthi Chrisochoidou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.